|
|
Volumn 89, Issue 4, 2014, Pages 704-708
|
|
A tale of two cities in China: Hong Kong and Shenzhen
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HEPATITIS B VACCINE;
NEW DRUG;
PEMETREXED;
ARTICLE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER EPIDEMIOLOGY;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER SCREENING;
CHINA;
CHINESE MEDICINE;
COLORECTAL CANCER;
ECONOMIC ASPECT;
GOVERNMENT;
GROSS NATIONAL PRODUCT;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HONG KONG;
HOSPICE CARE;
HUMAN;
LIFE EXPECTANCY;
MEDICAL EDUCATION;
MEDICAL SOCIETY;
ONCOLOGY;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
PROSTATE CANCER;
REIMBURSEMENT;
UTERINE CERVIX CANCER;
VACCINATION;
ANTINEOPLASTIC AGENTS;
CHINA;
CITIES;
DRUG APPROVAL;
FEES AND CHARGES;
HEALTH SERVICES ACCESSIBILITY;
HEALTH SYSTEMS PLANS;
HISTORY, 19TH CENTURY;
HISTORY, 20TH CENTURY;
HONG KONG;
HOSPICE CARE;
HUMANS;
MEDICAL ONCOLOGY;
NATIONAL HEALTH PROGRAMS;
NEOPLASMS;
PALLIATIVE CARE;
PILOT PROJECTS;
RADIOTHERAPY;
SOCIALISM;
TIME FACTORS;
WAITING LISTS;
|
|
EID: 84903192764
PISSN: 03603016
EISSN: 1879355X
Source Type: Journal
DOI: 10.1016/j.ijrobp.2013.12.053 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
